In this editorial, we will review emerging evidence for the relationship between sexual orientation, indoor tanning and melanoma and discuss implications for clinical practice, research and public health.
Browsing: Journals > Melanoma Management
This editorial discusses the impact of the numer of melanocytic nevi (moles) and the risk of developing melanoma.
This article provides a immunotherapy perspective of Ipilimumab, a CTLA-4-targeted monoclonal antibody, reviewing drug mechanism, blockade, combination therapies and future prospectives.
Discuss the history of the development of intralesional therapies, current effective therapies and the future direction of these injectable therapies.
In this research article the authors review the efficacy and safety of radiosurgery for melanoma brain metastases in patients treated with ipilimumab .
In this from editorial Melanoma Management the authors explore the use of vaccines in combination with dasatinib for the treatment of stage IIIB–IV melanoma.
Could dendritic cell vaccines be a promising therapeutic strategy for advanced melanoma? Read more in this article from Melanoma Management.
Could long-noncoding RNAs be utilized as novel circulating biomakers to aid the detection, diagnosis and prognosis of melanoma?
Meenhard Herlyn, Caspar Wistar Professor for Melanoma Research and Director of the Melanoma Research Center at The Wistar Institute (PA, USA) and Founding President of the Society for Melanoma Research speaks to Melanoma Management about his 40 years in melanoma research.